Sycamore Labs | $65,000,000 | (Mar 31, 2026)
Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
ABK Biomedical Inc.
Canada
- Halifax, Nova Scotia
- 15/10/2025
- Series D
- $35,000,000
Founded in 2012, we are focused on researching, developing, and commercializing breakthrough medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors.
With our multi-disciplinary experience in engineering, material science, oncology, medical science, regulatory, finance, business development, sales, marketing, and clinical study coordination we are staffed with the talent to drive the next level of technology for personalized healthcare in oncology.
- Industry Medical Equipment Manufacturing
- Website https://abkbiomedical.com/
- LinkedIn https://www.linkedin.com/company/abk-biomedical-inc-/
Related People
Michael ManganoFounder
United States -
Dana Point, California
Accomplished global executive leader with over thirty years' experience in the medical device industry. Member of Senior Leadership and Executive committees with history of success in building dynamic teams, leading organizational change, creating and shaping strategies, and executing programs leading directly to increased shareholder value. Vast experience in sales/marketing management, product development, strategic planning, international business, M&A, project management, and business model development.
OpenBox AI | $5,000,000 | (Mar 31, 2026)
Qodo | $70,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026)
Valinor(1) | $25,000,000 | (Mar 31, 2026)
Mars Men | $27,500,000 | (Mar 31, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)